{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:45:25Z","timestamp":1785433525361,"version":"3.56.0"},"reference-count":18,"publisher":"North Carolina Institute of Medicine","issue":"5","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Local governments have been given direct control over a substantial amount of opioid settlement funding. While state-level data sources are valuable inputs, city and county leaders should consider local data sources when making decisions to ensure timely responses to emerging threats, as is exemplified by the rise of xylazine.<\/jats:p>","DOI":"10.18043\/001c.123256","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T12:11:39Z","timestamp":1726575099000},"source":"Crossref","is-referenced-by-count":0,"title":["The Rise of Xylazine Shows Why Local Data Must Inform Policy and Spending Decisions"],"prefix":"10.18043","volume":"85","author":[{"given":"Jeremy","family":"Kourvelas","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/020f3ap87","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Tennessee at Knoxville","department":["Institute for Public Service"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7507","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1111\/1556-4029.15269","article-title":"Understanding research methods, limitations, and applications of drug data collected by the National Forensic Laboratory Information System (NFLIS-Drug)","volume":"68","author":"W. J. Pitts","year":"2023","journal-title":"J Forensic Sci"},{"key":"ref2","article-title":"The Need for Point-of-Care Testing of All Illicit Substances","author":"C. Cretsinger","year":"2023","journal-title":"University of Tennessee Substance Misuse and Addiction Resource for Tennessee"},{"key":"ref3","article-title":"Narcotics Detectives Becoming Increasingly Concerned About the Presence of Xylazine in Street Drugs","author":"D. Aaron","year":"2024","journal-title":"Metropolitan Nashville Police Department Office of Public Affairs"},{"key":"ref4","article-title":"Tennessee State-Subdivision Opioid Abatement Agreement","journal-title":"State of Tennessee Office of the Attorney General"},{"key":"ref5","article-title":"North Carolina Opioid Settlements","year":"2024"},{"key":"ref6","article-title":"UNC Street Drug Analysis Lab"},{"key":"ref7","article-title":"What is xylazine, and is it increasing overdose deaths in N.C.?","author":"G. Vitaglione","year":"2024","journal-title":"North Carolina Health News"},{"issue":"9","key":"ref8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3928\/02793695-20220809-05","article-title":"Recovery ecosystems: a whole health approach to substance use prevention and treatment","volume":"60","author":"M. N. Mumba","year":"2022","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"issue":"Suppl 6","key":"ref9","doi-asserted-by":"publisher","first-page":"S286","DOI":"10.1097\/PHH.0000000000001546","article-title":"Comparing practices used in overdose fatality review teams to recommended implementation guidelines","volume":"28","author":"B. Ray","year":"2022","journal-title":"J Public Health Manag Pract"},{"issue":"21","key":"ref10","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1001\/jama.2019.17144","article-title":"The opioid crisis, corporate responsibility, and lessons from the Tobacco Master Settlement Agreement","volume":"322","author":"C. Healton","year":"2019","journal-title":"JAMA"},{"key":"ref11","article-title":"Opioid and Substance Use Action Plan Data Dashboard","author":"North Carolina Department of Health and Human Services"},{"key":"ref12","article-title":"Tennessee Drug Overdose Dashboard","author":"Tennessee Department of Health"},{"key":"ref13","article-title":"The Growing Threat of Xylazine and its Mixture with Illicit Drugs","year":"2022","journal-title":"Drug Enforcement Administration"},{"key":"ref14","series-title":"StatPearls","article-title":"Xylazine Toxicity","author":"B. N. Papudesi","year":"2024"},{"issue":"5","key":"ref15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.15585\/mmwr.mm7305a4","article-title":"Comparison of administration of 8-milligram and 4-milligram intranasal naloxone by law enforcement during response to suspected opioid overdose \u2014 New York, March 2022\u2013August 2023","volume":"73","author":"E. R. Payne","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"ref16","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1101\/2023.03.13.23287215","article-title":"Self-reported xylazine experiences: a mixed methods study of Reddit subscribers","volume":"17","author":"A. Spadaro","year":"2023","journal-title":"medRxiv [Preprint]"},{"key":"ref17","article-title":"Emerging Trends Brief: Xylazine in Tennessee","year":"2024","journal-title":"Tennessee Department of Health \u2013 Office of Informatics & Analytics"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1101\/2023.08.24.23294567","article-title":"Xylazine in drug seizure reports and overdose deaths in the US, 2018-2022","author":"M. Cano","year":"2023","journal-title":"medRxiv"}],"container-title":["North Carolina Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ncmedicaljournal.com\/article\/123256-the-rise-of-xylazine-shows-why-local-data-must-inform-policy-and-spending-decisions","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:12:40Z","timestamp":1780603960000},"score":1,"resource":{"primary":{"URL":"https:\/\/ncmedicaljournal.com\/article\/123256-the-rise-of-xylazine-shows-why-local-data-must-inform-policy-and-spending-decisions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":18,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.18043\/001c.123256","relation":{},"ISSN":["2379-4313","0029-2559"],"issn-type":[{"value":"2379-4313","type":"electronic"},{"value":"0029-2559","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,17]]}}}